Logo image of DLA

DELTA APPAREL INC (DLA) Stock Fundamental Analysis

USA - NYSEARCA:DLA - US2473681037 - Common Stock

0.58 USD
+0.08 (+16%)
Last: 6/28/2024, 8:04:00 PM
0.4478 USD
-0.13 (-22.79%)
Pre-Market: 7/1/2024, 8:03:36 AM
Fundamental Rating

2

DLA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 48 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the profitability and financial health of DLA have multiple concerns. DLA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DLA had negative earnings in the past year.
In the past year DLA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: DLA reported negative net income in multiple years.
Of the past 5 years DLA 4 years had a positive operating cash flow.
DLA Yearly Net Income VS EBIT VS OCF VS FCFDLA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

1.2 Ratios

With a Return On Assets value of -18.44%, DLA is not doing good in the industry: 84.00% of the companies in the same industry are doing better.
With a Return On Equity value of -63.26%, DLA is not doing good in the industry: 86.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -18.44%
ROE -63.26%
ROIC N/A
ROA(3y)0.38%
ROA(5y)0.16%
ROE(3y)0.36%
ROE(5y)-0.19%
ROIC(3y)N/A
ROIC(5y)N/A
DLA Yearly ROA, ROE, ROICDLA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

DLA's Gross Margin of 10.18% is on the low side compared to the rest of the industry. DLA is outperformed by 96.00% of its industry peers.
DLA's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for DLA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.18%
GM growth 5Y-8.91%
DLA Yearly Profit, Operating, Gross MarginsDLA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20

More info and screens

3

2. Health

2.1 Basic Checks

DLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DLA has been increased compared to 1 year ago.
The number of shares outstanding for DLA has been increased compared to 5 years ago.
DLA has a worse debt/assets ratio than last year.
DLA Yearly Shares OutstandingDLA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
DLA Yearly Total Debt VS Total AssetsDLA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 1.03, we must say that DLA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of DLA (1.03) is worse than 76.00% of its industry peers.
DLA has a debt to FCF ratio of 1.98. This is a very positive value and a sign of high solvency as it would only need 1.98 years to pay back of all of its debts.
DLA's Debt to FCF ratio of 1.98 is in line compared to the rest of the industry. DLA outperforms 60.00% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that DLA is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.15, DLA is doing good in the industry, outperforming 64.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.98
Altman-Z 1.03
ROIC/WACCN/A
WACC6.87%
DLA Yearly LT Debt VS Equity VS FCFDLA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

DLA has a Current Ratio of 1.01. This is a normal value and indicates that DLA is financially healthy and should not expect problems in meeting its short term obligations.
DLA has a worse Current ratio (1.01) than 90.00% of its industry peers.
DLA has a Quick Ratio of 1.01. This is a bad value and indicates that DLA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DLA (0.21) is worse than 98.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.21
DLA Yearly Current Assets VS Current LiabilitesDLA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for DLA have decreased strongly by -423.30% in the last year.
Looking at the last year, DLA shows a very negative growth in Revenue. The Revenue has decreased by -22.49% in the last year.
Measured over the past years, DLA shows a small growth in Revenue. The Revenue has been growing by 0.99% on average per year.
EPS 1Y (TTM)-423.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-153%
Revenue 1Y (TTM)-22.49%
Revenue growth 3Y2.92%
Revenue growth 5Y0.99%
Sales Q2Q%-28.45%

3.2 Future

Based on estimates for the next years, DLA will show a very strong growth in Earnings Per Share. The EPS will grow by 34.37% on average per year.
Based on estimates for the next years, DLA will show a decrease in Revenue. The Revenue will decrease by -3.00% on average per year.
EPS Next Y34.98%
EPS Next 2Y34.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.35%
Revenue Next 2Y-3%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DLA Yearly Revenue VS EstimatesDLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
DLA Yearly EPS VS EstimatesDLA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DLA. In the last year negative earnings were reported.
Also next year DLA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DLA Price Earnings VS Forward Price EarningsDLA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of DLA indicates a rather cheap valuation: DLA is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.06
EV/EBITDA N/A
DLA Per share dataDLA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

A more expensive valuation may be justified as DLA's earnings are expected to grow with 34.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.37%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DLA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DELTA APPAREL INC

NYSEARCA:DLA (6/28/2024, 8:04:00 PM)

Premarket: 0.4478 -0.13 (-22.79%)

0.58

+0.08 (+16%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)05-08 2024-05-08/amc
Earnings (Next)08-01 2024-08-01/amc
Inst Owners0.99%
Inst Owner Change0%
Ins Owners15.21%
Ins Owner Change0%
Market Cap4.09M
Analysts80
Price Target8.16 (1306.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.94%
Min EPS beat(2)-155.61%
Max EPS beat(2)-2.27%
EPS beat(4)0
Avg EPS beat(4)-206.67%
Min EPS beat(4)-642.57%
Max EPS beat(4)-2.27%
EPS beat(8)0
Avg EPS beat(8)-140.72%
EPS beat(12)4
Avg EPS beat(12)-73.12%
EPS beat(16)8
Avg EPS beat(16)-24.1%
Revenue beat(2)0
Avg Revenue beat(2)-16.43%
Min Revenue beat(2)-18.41%
Max Revenue beat(2)-14.44%
Revenue beat(4)0
Avg Revenue beat(4)-12.24%
Min Revenue beat(4)-18.41%
Max Revenue beat(4)-6.7%
Revenue beat(8)1
Avg Revenue beat(8)-8.29%
Revenue beat(12)4
Avg Revenue beat(12)-4.6%
Revenue beat(16)4
Avg Revenue beat(16)-3.65%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.06
P/OCF 0.06
P/B 0.04
P/tB 0.06
EV/EBITDA N/A
EPS(TTM)-5.39
EYN/A
EPS(NY)-0.74
Fwd EYN/A
FCF(TTM)9.08
FCFY1565.1%
OCF(TTM)9.37
OCFY1615.21%
SpS50.58
BVpS15.13
TBVpS9.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.44%
ROE -63.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.18%
FCFM 17.95%
ROA(3y)0.38%
ROA(5y)0.16%
ROE(3y)0.36%
ROE(5y)-0.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.18%
GM growth 5Y-8.91%
F-Score4
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.98
Debt/EBITDA N/A
Cap/Depr 13.98%
Cap/Sales 0.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 0.21
Altman-Z 1.03
F-Score4
WACC6.87%
ROIC/WACCN/A
Cap/Depr(3y)63.4%
Cap/Depr(5y)62.44%
Cap/Sales(3y)2.01%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-423.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-153%
EPS Next Y34.98%
EPS Next 2Y34.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.49%
Revenue growth 3Y2.92%
Revenue growth 5Y0.99%
Sales Q2Q%-28.45%
Revenue Next Year-11.35%
Revenue Next 2Y-3%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1027.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year177.99%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y856.11%
FCF growth 3Y-28.33%
FCF growth 5Y-11.5%
OCF growth 1Y544.16%
OCF growth 3Y-29.34%
OCF growth 5Y-11.99%